Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease
NCT07348250
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease (PD)
Parkinson's Disease
Parkinson's Disease (Disorder)
Interventions
DRUG:
[18F]MK-0947
Sponsor
Invicro
Collaborators
[object Object]